Starboard Delivers Open Letter to Bristol-Myers Squibb Stockholders
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
Bristol-Myers Squibb (BMY) Responded to Starboard's Letter, Confident in Combination with Celgene (CELG)
February 28, 2019 12:00 PM ESTBristol-Myers Squibb Company (NYSE: BMY) today issued the following statement in response to a letter from Starboard Value:
Bristol-Myers Squibb welcomes the opinions of all of its stockholders and will review Starboards letter and respond in due course.
The Bristol-Myers Squibb Board and management team are confident that our combination with Celgene Corporation (NASDAQ: CELG) will create a premier biopharma company and deliver substantial benefits to our stockholders. This combination is consistent with our strategy and is the... More
